ESC 365 - Oral anticoagulants and their effect on kidneys function, is warfarin safe?

ESC Premium Access

Oral anticoagulants and their effect on kidneys function, is warfarin safe?

Session: Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

Topic: Oral Anticoagulation

Speaker: Associate Professor T. Novikova (Saint Petersburg, RU)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Tatiana Novikova

North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg (Russian Federation)

0 follower

13 more presentations in this session

Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in newly diagnosed non-valvular atrial fibrillation.

Speaker: Doctor L. Bergamaschi (Bologna, IT)

Inappropriate dosing of non-vitamin K oral anticoagulants (NOACs) in atrial fibrillation patients in Europe

Speaker: Ms I. Palau (London, GB)

Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis

Speaker: Doctor Y. Gue (Liverpool, GB)

Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Worsening of renal function in atrial fibrillation patients with stage 3 or 4 chronic kidney disease treated with warfarin or rivaroxaban - evidence from the real-world CALLIPER study in the US claims

Speaker: Doctor T. Vaitsiakhovich (Berlin, DE)

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

Speakers: Associate Professor T. Novikova, Doctor L. Bergamaschi, Ms I. Palau, Doctor Y. Gue, Professor P. Hjemdahl...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources